Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6793066

CCOC(=O)c1c2c(nn1CCCNCCc1cccs1)-c1ccncc1CC2.O=C(O)C(F)(F)F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 3/20 0.38
P2RY12 Q9H244 2/20 0.36
ALDH1A1 P00352 7/20 0.35
NPC1 O15118 4/20 0.35
KDM4E B2RXH2 2/20 0.35
CDK4 P11802 1/20 0.34
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34
CCND3 P30281 1/20 0.34
CCNA1 P78396 1/20 0.34
CDK6 Q00534 1/20 0.34
HPGD P15428 4/20 0.34
HIF1A Q16665 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
SMN1; SMN2 Q16637 4/20 0.33
RAB9A P51151 3/20 0.33
CDC7 O00311 1/20 0.32
DBF4 Q9UBU7 1/20 0.32
SLC26A6 Q9BXS9 1/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4257701 0.91 ROCK2 (0.39) ROCK2ALDH1A1NPC1KDM4ECDK2
Trifluoroacetic Acid SCHEMBL6788639 0.90 ALDH1A1 (0.39) ROCK2P2RY12ALDH1A1NPC1CDK4
SCHEMBL4257707 0.89 ROCK2 (0.38) ROCK2ALDH1A1NPC1KDM4E
SCHEMBL6792350 0.86 ROCK2 (0.42) ROCK2ALDH1A1NPC1KDM4ECDK2
Trifluoroacetic Acid SCHEMBL1658074 0.84 ROCK2 (0.37) ROCK2ALDH1A1KDM4ECDK2HPGD
Trifluoroacetic Acid SCHEMBL6801179 0.82 CDK4 (0.32) ROCK2CDK4CCNA2CDK2CCND3
SCHEMBL1658076 0.82 ROCK2 (0.36) ROCK2KDM4ESMN1; SMN2CYP2C19MEN1
Trifluoroacetic Acid SCHEMBL4271415 0.80 AURKA (0.32) ROCK2CCNA2CDK2CCNA1
Trifluoroacetic Acid SCHEMBL4270585 0.80 CDK2 (0.33) ROCK2CCNA2CDK2CCNA1
Trifluoroacetic Acid SCHEMBL6792793 0.79 CDK2 (0.37) ROCK2ALDH1A1NPC1KDM4ECDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040127492-A1 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 PHARMACIA CORPORATION 2004-07-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127492-A1 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 MKNK2, MAPKAPK2, MAP3K2 ROCK2 317/4885P2RY12 715/4885ALDH1A1 4449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.